Dermavant Sciences to Present Data on Tapinarof for Psoriasis and Atopic Dermatitis at the 2019 American Academy of Dermatology Annual Meeting

    NEXT STORY
    Zai Lab to Announce Full Year 2018 Financial Results
    PREV STORY
    Global Antifungal Drugs Market Analysis, Forecast & Opportunities, 2013-2018 & 2023 – Azoles Class Antifungals are Predicted to Hold their Dominant Position in the Market
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Establishment Labs Announces Positive Clinical Study Results for its Motiva Implants® Published in the Aesthetics Surgery Journal

    NEW YORK, Sept. 14, 2017 (GLOBE NEWSWIRE) -- Establishment Labs, a global medical device ...

    author_avatar
    NASDAQ Market News

    ERBA Diagnostics to Commence Trading on OTC Markets’ Pink Open Market After Delisting by the NYSE MKT

    MIAMI, Sept. 30, 2016 (GLOBE NEWSWIRE) -- ERBA Diagnostics, Inc. (the “Company”), a fully ...

    author_avatar
    NASDAQ Market News

    Teleflex Announces Second Quarter 2019 Earnings Conference Call Information 

    author_avatar
    NASDAQ Market News